 | • レポートコード：MRC2012A8432 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、性機能障害治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。性機能障害治療薬の種類別市場規模（経口療法、海綿体内療法、ホルモン療法、経尿道的療法）、用途別市場規模（男性、女性）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Takeda、Eli Lilly、GlaxoSmithKline、Teva Pharmaceutical Industries、Merck、Emotional Brain、Bayer、AbbVie、Apricus Biosciences、Vietstar Biomedical Research、Ivix LLX、S1 Biopharma、Leadiant Biosciences、NexMed、 ・地域別グローバル市場分析 2015年-2020年 ・性機能障害治療薬の北米市場（アメリカ、カナダ、メキシコ） ・性機能障害治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・性機能障害治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・性機能障害治療薬の南米市場（ブラジル、アルゼンチン） ・性機能障害治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口療法、海綿体内療法、ホルモン療法、経尿道的療法 ・用途別分析：男性、女性 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Sexual Dysfunction Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Sexual Dysfunction Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Sexual Dysfunction Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Sexual Dysfunction Drugs market has been segmented into
Oral Therapy
Intracavernosal Therapy
Hormonal Therapy
Transurethral Therapy
By Application, Sexual Dysfunction Drugs has been segmented into:
Male
Female
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sexual Dysfunction Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Sexual Dysfunction Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sexual Dysfunction Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Sexual Dysfunction Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Sexual Dysfunction Drugs Market Share Analysis
Sexual Dysfunction Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sexual Dysfunction Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sexual Dysfunction Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Sexual Dysfunction Drugs are:
Pfizer
Takeda
Eli Lilly
GlaxoSmithKline
Teva Pharmaceutical Industries
Merck
Emotional Brain
Bayer
AbbVie
Apricus Biosciences
Vietstar Biomedical Research
Ivix LLX
S1 Biopharma
Leadiant Biosciences
NexMed
Among other players domestic and global, Sexual Dysfunction Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sexual Dysfunction Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sexual Dysfunction Drugs, with price, sales, revenue and global market share of Sexual Dysfunction Drugs in 2018 and 2019.
Chapter 3, the Sexual Dysfunction Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sexual Dysfunction Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Sexual Dysfunction Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Sexual Dysfunction Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Sexual Dysfunction Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sexual Dysfunction Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral Therapy
1.2.3 Intracavernosal Therapy
1.2.4 Hormonal Therapy
1.2.5 Transurethral Therapy
1.3 Market Analysis by Application
1.3.1 Overview: Global Sexual Dysfunction Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Male
1.3.3 Female
1.4 Overview of Global Sexual Dysfunction Drugs Market
1.4.1 Global Sexual Dysfunction Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Takeda SWOT Analysis
2.2.4 Takeda Product and Services
2.2.5 Takeda Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eli Lilly SWOT Analysis
2.3.4 Eli Lilly Product and Services
2.3.5 Eli Lilly Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GlaxoSmithKline SWOT Analysis
2.4.4 GlaxoSmithKline Product and Services
2.4.5 GlaxoSmithKline Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Teva Pharmaceutical Industries
2.5.1 Teva Pharmaceutical Industries Details
2.5.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Teva Pharmaceutical Industries SWOT Analysis
2.5.4 Teva Pharmaceutical Industries Product and Services
2.5.5 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Emotional Brain
2.7.1 Emotional Brain Details
2.7.2 Emotional Brain Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Emotional Brain SWOT Analysis
2.7.4 Emotional Brain Product and Services
2.7.5 Emotional Brain Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bayer SWOT Analysis
2.8.4 Bayer Product and Services
2.8.5 Bayer Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 AbbVie
2.9.1 AbbVie Details
2.9.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 AbbVie SWOT Analysis
2.9.4 AbbVie Product and Services
2.9.5 AbbVie Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Apricus Biosciences
2.10.1 Apricus Biosciences Details
2.10.2 Apricus Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Apricus Biosciences SWOT Analysis
2.10.4 Apricus Biosciences Product and Services
2.10.5 Apricus Biosciences Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Vietstar Biomedical Research
2.11.1 Vietstar Biomedical Research Details
2.11.2 Vietstar Biomedical Research Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Vietstar Biomedical Research SWOT Analysis
2.11.4 Vietstar Biomedical Research Product and Services
2.11.5 Vietstar Biomedical Research Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Ivix LLX
2.12.1 Ivix LLX Details
2.12.2 Ivix LLX Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Ivix LLX SWOT Analysis
2.12.4 Ivix LLX Product and Services
2.12.5 Ivix LLX Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 S1 Biopharma
2.13.1 S1 Biopharma Details
2.13.2 S1 Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 S1 Biopharma SWOT Analysis
2.13.4 S1 Biopharma Product and Services
2.13.5 S1 Biopharma Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Leadiant Biosciences
2.14.1 Leadiant Biosciences Details
2.14.2 Leadiant Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Leadiant Biosciences SWOT Analysis
2.14.4 Leadiant Biosciences Product and Services
2.14.5 Leadiant Biosciences Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 NexMed
2.15.1 NexMed Details
2.15.2 NexMed Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 NexMed SWOT Analysis
2.15.4 NexMed Product and Services
2.15.5 NexMed Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Sexual Dysfunction Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Sexual Dysfunction Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Sexual Dysfunction Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Sexual Dysfunction Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Sexual Dysfunction Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Sexual Dysfunction Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Sexual Dysfunction Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
4.5 South America Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Sexual Dysfunction Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Sexual Dysfunction Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Sexual Dysfunction Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Sexual Dysfunction Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Sexual Dysfunction Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Sexual Dysfunction Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
6.3 UK Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
6.4 France Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Sexual Dysfunction Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Sexual Dysfunction Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Sexual Dysfunction Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
7.5 India Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Sexual Dysfunction Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Sexual Dysfunction Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Sexual Dysfunction Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Sexual Dysfunction Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Sexual Dysfunction Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Sexual Dysfunction Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Sexual Dysfunction Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Sexual Dysfunction Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Sexual Dysfunction Drugs Price by Type (2015-2020)
11 Global Sexual Dysfunction Drugs Market Segment by Application
11.1 Global Sexual Dysfunction Drugs Sales Market Share by Application (2015-2020)
11.2 Global Sexual Dysfunction Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Sexual Dysfunction Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Sexual Dysfunction Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Sexual Dysfunction Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Sexual Dysfunction Drugs Market Forecast (2021-2025)
12.2.2 Europe Sexual Dysfunction Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Sexual Dysfunction Drugs Market Forecast (2021-2025)
12.2.4 South America Sexual Dysfunction Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Sexual Dysfunction Drugs Market Forecast (2021-2025)
12.3 Sexual Dysfunction Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Sexual Dysfunction Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Sexual Dysfunction Drugs Market Share Forecast by Type (2021-2025)
12.4 Sexual Dysfunction Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Sexual Dysfunction Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Sexual Dysfunction Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Sexual Dysfunction Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sexual Dysfunction Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sexual Dysfunction Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Sexual Dysfunction Drugs Major Business
Table 9. Pfizer Sexual Dysfunction Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Sexual Dysfunction Drugs Product and Services
Table 12. Pfizer Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Takeda Basic Information, Manufacturing Base and Competitors
Table 14. Takeda Sexual Dysfunction Drugs Major Business
Table 15. Takeda Sexual Dysfunction Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Takeda SWOT Analysis
Table 17. Takeda Sexual Dysfunction Drugs Product and Services
Table 18. Takeda Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly Sexual Dysfunction Drugs Major Business
Table 21. Eli Lilly Sexual Dysfunction Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Eli Lilly SWOT Analysis
Table 23. Eli Lilly Sexual Dysfunction Drugs Product and Services
Table 24. Eli Lilly Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 26. GlaxoSmithKline Sexual Dysfunction Drugs Major Business
Table 27. GlaxoSmithKline Sexual Dysfunction Drugs Total Revenue (USD Million) (2017-2018)
Table 28. GlaxoSmithKline SWOT Analysis
Table 29. GlaxoSmithKline Sexual Dysfunction Drugs Product and Services
Table 30. GlaxoSmithKline Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 32. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Major Business
Table 33. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Teva Pharmaceutical Industries SWOT Analysis
Table 35. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product and Services
Table 36. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck Basic Information, Manufacturing Base and Competitors
Table 38. Merck Sexual Dysfunction Drugs Major Business
Table 39. Merck Sexual Dysfunction Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Merck SWOT Analysis
Table 41. Merck Sexual Dysfunction Drugs Product and Services
Table 42. Merck Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Emotional Brain Basic Information, Manufacturing Base and Competitors
Table 44. Emotional Brain Sexual Dysfunction Drugs Major Business
Table 45. Emotional Brain Sexual Dysfunction Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Emotional Brain SWOT Analysis
Table 47. Emotional Brain Sexual Dysfunction Drugs Product and Services
Table 48. Emotional Brain Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Bayer Basic Information, Manufacturing Base and Competitors
Table 50. Bayer Sexual Dysfunction Drugs Major Business
Table 51. Bayer Sexual Dysfunction Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Bayer SWOT Analysis
Table 53. Bayer Sexual Dysfunction Drugs Product and Services
Table 54. Bayer Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. AbbVie Basic Information, Manufacturing Base and Competitors
Table 56. AbbVie Sexual Dysfunction Drugs Major Business
Table 57. AbbVie Sexual Dysfunction Drugs Total Revenue (USD Million) (2017-2018)
Table 58. AbbVie SWOT Analysis
Table 59. AbbVie Sexual Dysfunction Drugs Product and Services
Table 60. AbbVie Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Apricus Biosciences Basic Information, Manufacturing Base and Competitors
Table 62. Apricus Biosciences Sexual Dysfunction Drugs Major Business
Table 63. Apricus Biosciences Sexual Dysfunction Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Apricus Biosciences SWOT Analysis
Table 65. Apricus Biosciences Sexual Dysfunction Drugs Product and Services
Table 66. Apricus Biosciences Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Vietstar Biomedical Research Basic Information, Manufacturing Base and Competitors
Table 68. Vietstar Biomedical Research Sexual Dysfunction Drugs Major Business
Table 69. Vietstar Biomedical Research Sexual Dysfunction Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Vietstar Biomedical Research SWOT Analysis
Table 71. Vietstar Biomedical Research Sexual Dysfunction Drugs Product and Services
Table 72. Vietstar Biomedical Research Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Ivix LLX Basic Information, Manufacturing Base and Competitors
Table 74. Ivix LLX Sexual Dysfunction Drugs Major Business
Table 75. Ivix LLX Sexual Dysfunction Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Ivix LLX SWOT Analysis
Table 77. Ivix LLX Sexual Dysfunction Drugs Product and Services
Table 78. Ivix LLX Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. S1 Biopharma Basic Information, Manufacturing Base and Competitors
Table 80. S1 Biopharma Sexual Dysfunction Drugs Major Business
Table 81. S1 Biopharma Sexual Dysfunction Drugs Total Revenue (USD Million) (2017-2018)
Table 82. S1 Biopharma SWOT Analysis
Table 83. S1 Biopharma Sexual Dysfunction Drugs Product and Services
Table 84. S1 Biopharma Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Leadiant Biosciences Basic Information, Manufacturing Base and Competitors
Table 86. Leadiant Biosciences Sexual Dysfunction Drugs Major Business
Table 87. Leadiant Biosciences Sexual Dysfunction Drugs Total Revenue (USD Million) (2017-2018)
Table 88. Leadiant Biosciences SWOT Analysis
Table 89. Leadiant Biosciences Sexual Dysfunction Drugs Product and Services
Table 90. Leadiant Biosciences Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. NexMed Basic Information, Manufacturing Base and Competitors
Table 92. NexMed Sexual Dysfunction Drugs Major Business
Table 93. NexMed Sexual Dysfunction Drugs Total Revenue (USD Million) (2017-2018)
Table 94. NexMed SWOT Analysis
Table 95. NexMed Sexual Dysfunction Drugs Product and Services
Table 96. NexMed Sexual Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Global Sexual Dysfunction Drugs Sales by Manufacturer (2018-2019) (K Pcs)
Table 98. Global Sexual Dysfunction Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 99. Global Sexual Dysfunction Drugs Sales by Regions (2015-2020) (K Pcs)
Table 100. Global Sexual Dysfunction Drugs Sales Market Share by Regions (2015-2020)
Table 101. Global Sexual Dysfunction Drugs Revenue by Regions (2015-2020) (USD Million)
Table 102. North America Sexual Dysfunction Drugs Sales by Countries (2015-2020) (K Pcs)
Table 103. North America Sexual Dysfunction Drugs Sales Market Share by Countries (2015-2020)
Table 104. North America Sexual Dysfunction Drugs Revenue by Countries (2015-2020) (USD Million)
Table 105. North America Sexual Dysfunction Drugs Revenue Market Share by Countries (2015-2020)
Table 106. Europe Sexual Dysfunction Drugs Sales by Countries (2015-2020) (K Pcs)
Table 107. Europe Sexual Dysfunction Drugs Sales Market Share by Countries (2015-2020)
Table 108. Europe Sexual Dysfunction Drugs Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Sexual Dysfunction Drugs Sales by Regions (2015-2020) (K Pcs)
Table 110. Asia-Pacific Sexual Dysfunction Drugs Sales Market Share by Regions (2015-2020)
Table 111. Asia-Pacific Sexual Dysfunction Drugs Revenue by Regions (2015-2020) (USD Million)
Table 112. South America Sexual Dysfunction Drugs Sales by Countries (2015-2020) (K Pcs)
Table 113. South America Sexual Dysfunction Drugs Sales Market Share by Countries (2015-2020)
Table 114. South America Sexual Dysfunction Drugs Revenue by Countries (2015-2020) (USD Million)
Table 115. South America Sexual Dysfunction Drugs Revenue Market Share by Countries (2015-2020)
Table 116. Middle East & Africa Sexual Dysfunction Drugs Sales by Countries (2015-2020) (K Pcs)
Table 117. Middle East & Africa Sexual Dysfunction Drugs Sales Market Share by Countries (2015-2020)
Table 118. Middle East & Africa Sexual Dysfunction Drugs Revenue by Countries (2015-2020) (USD Million)
Table 119. Middle East & Africa Sexual Dysfunction Drugs Revenue Market Share by Countries (2015-2020)
Table 120. Global Sexual Dysfunction Drugs Sales by Type (2015-2020) (K Pcs)
Table 121. Global Sexual Dysfunction Drugs Sales Share by Type (2015-2020)
Table 122. Global Sexual Dysfunction Drugs Revenue by Type (2015-2020) (USD Million)
Table 123. Global Sexual Dysfunction Drugs Revenue Share by Type (2015-2020)
Table 124. Global Sexual Dysfunction Drugs Sales by Application (2015-2020) (K Pcs)
Table 125. Global Sexual Dysfunction Drugs Sales Share by Application (2015-2020)
Table 126. Global Sexual Dysfunction Drugs Sales Forecast by Regions (2021-2025) (K Pcs)
Table 127. Global Sexual Dysfunction Drugs Market Share Forecast by Regions (2021-2025)
Table 128. Global Sexual Dysfunction Drugs Sales Forecast by Type (2021-2025) (K Pcs)
Table 129. Global Sexual Dysfunction Drugs Market Share Forecast by Type (2021-2025)
Table 130. Global Sexual Dysfunction Drugs Sales Forecast by Application (2021-2025)
Table 131. Global Sexual Dysfunction Drugs Market Share Forecast by Application (2021-2025)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Sexual Dysfunction Drugs Picture
Figure 2. Global Sales Market Share of Sexual Dysfunction Drugs by Type in 2019
Figure 3. Oral Therapy Picture
Figure 4. Intracavernosal Therapy Picture
Figure 5. Hormonal Therapy Picture
Figure 6. Transurethral Therapy Picture
Figure 7. Sexual Dysfunction Drugs Sales Market Share by Application in 2018
Figure 8. Male Picture
Figure 9. Female Picture
Figure 10. Global Sexual Dysfunction Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Sexual Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Sexual Dysfunction Drugs Sales Market Share by Manufacturer in 2019
Figure 31. Global Sexual Dysfunction Drugs Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Sexual Dysfunction Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Sexual Dysfunction Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 36. Global Sexual Dysfunction Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Sexual Dysfunction Drugs Revenue Market Share by Regions (2015-2020)
Figure 38. Global Sexual Dysfunction Drugs Revenue Market Share by Regions in 2018
Figure 39. North America Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
Figure 40. Europe Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
Figure 42. South America Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020)
Figure 44. North America Sexual Dysfunction Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Sexual Dysfunction Drugs Sales Market Share by Countries (2015-2020)
Figure 46. North America Sexual Dysfunction Drugs Sales Market Share by Countries in 2018
Figure 47. North America Sexual Dysfunction Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Sexual Dysfunction Drugs Revenue Market Share by Countries in 2018
Figure 49. United States Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 50. Canada Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 51. Mexico Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Europe Sexual Dysfunction Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Sexual Dysfunction Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Sexual Dysfunction Drugs Revenue Market Share by Countries in 2019
Figure 55. Germany Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. UK Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. France Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Italy Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Asia-Pacific Sexual Dysfunction Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Sexual Dysfunction Drugs Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Sexual Dysfunction Drugs Revenue Market Share by Regions 2019
Figure 63. China Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Korea Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. India Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Southeast Asia Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. South America Sexual Dysfunction Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Sexual Dysfunction Drugs Sales Market Share by Countries in 2019
Figure 70. South America Sexual Dysfunction Drugs Revenue Market Share by Countries in 2019
Figure 71. Brazil Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Argentina Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Middle East and Africa Sexual Dysfunction Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Sexual Dysfunction Drugs Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Sexual Dysfunction Drugs Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Sexual Dysfunction Drugs Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Egypt Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Turkey Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. South Africa Sexual Dysfunction Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Global Sexual Dysfunction Drugs Sales and Growth Rate (2021-2025) (K Pcs)
Figure 82. Global Sexual Dysfunction Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Sexual Dysfunction Drugs Market Forecast (2021-2025) (K Pcs)
Figure 84. Europe Sales Sexual Dysfunction Drugs Market Forecast (2021-2025) (K Pcs)
Figure 85. Asia-Pacific Sales Sexual Dysfunction Drugs Market Forecast (2021-2025) (K Pcs)
Figure 86. South America Sales Sexual Dysfunction Drugs Market Forecast (2021-2025) (K Pcs)
Figure 87. Middle East & Africa Sales Sexual Dysfunction Drugs Market Forecast (2021-2025) (K Pcs)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
性機能障害治療薬の世界市場（～2026年） Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in th…- 勃起不全治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Erectile Dysfunction Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 女性用性的欲求低下障害（HSDD）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Female Hypoactive Sexual Desire Disorder Therapeutics Market The global Female Hypoactive Sexual Desire Disorder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Female …
- 画期的治療薬の世界市場（～2026年） Breakthrough therapy drugs are intended to treat serious and life-threatening conditions. The breakthrough therapy is the designation given by FDA for the drugs when there is a preliminary clinical evidence indicates that the drug proves a substantial improvement over available drug treatment. Two f…
- 勃起不全（ED）の世界市場（～2026年） The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels. The ED drugs segment led the market and accounted for almost 80% of the market share in terms of…